Sarcomatous Lesions of the Stomach

Burgess, John N.; Dockerty, Malcolm B.; ReMine, William H.

doi:10.1097/00000658-197105000-00015

Cited by 47 publications

(18 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Chemotherapy has been recommended for patients with unresectable bulky tumors [29,30], B symptoms [30], nodal or serosal involvement [28], and extensive stage HE disease [20,29]. In one report of patients with stage IE and HE disease, 75% of the treatment failures were the result of distant metastases [26].…”

Section: Chemotherapymentioning

confidence: 99%

Management of Stage IE Primary Gastric Lymphoma

Durr

Bonner

Strickler³

et al. 1995

Acta Haematol

View full text Add to dashboard Cite

From 1975 to 1991, stage IE gastric lymphoma was diagnosed or treated in 40 patients at our institution. Thirty-five evaluable patients were the subject of this analysis (median age, 63 years). All histologic specimens were reviewed and classified according to the working formulation. Immunohistochemical stains were performed in 33 of 35 cases. The following histologic subtypes were identified: 26 patients had diffuse large cell, 2 had diffuse mixed cell, and 7 had mucosa-associated lymphocytic lymphoma (small lymphocytic lymphoma with features of MALT lymphoma). Of the 35 patients, 30 (86%) underwent laparotomy, with subtotal or total gastrectomy performed in 29. After gastrectomy, 17 patients had radiation therapy, 3 had chemotherapy, 2 had radiation plus chemotherapy, and 7 had no further treatment. Five patients were diagnosed with endoscopic biopsy and had radiation therapy, chemotherapy, or both without further surgical treatment. The median follow-up period was 69.2 months. The commonest presenting symptom was pain. The 5-year disease-free survival was 90% for the entire group and 88% for the 28 patients with working formulation intermediate histology. For patients with MALT lymphoma, the 5-year disease-free survival was 100%. The prognosis for patients with stage IE working formulation intermediate-histology gastric lymphoma is good and for those with stage IE MALT lymphoma, excellent.

show abstract

Section: Chemotherapymentioning

confidence: 99%

Management of Stage IE Primary Gastric Lymphoma

Durr

Bonner

Strickler³

et al. 1995

Acta Haematol

View full text Add to dashboard Cite

show abstract

“…Non-Hodgkin's lymphoma (NHL) of the gastrointestinal (GI) tract accounts for about 1-2% of all cases of GI malignancy (Burgess et al, 1971;Freeman et al, 1972). It comprises 1-7% of all malignancies of the stomach (Burgess et al, 1971;Freeman et al, 1972;Fleming et al, 1982), 20% of those in the small bowel and less than 0.5% of those in the large bowel (Cutler et al, 1975).…”

mentioning

confidence: 99%

“…It comprises 1-7% of all malignancies of the stomach (Burgess et al, 1971;Freeman et al, 1972;Fleming et al, 1982), 20% of those in the small bowel and less than 0.5% of those in the large bowel (Cutler et al, 1975). However, 40% of all primary extranodal NHL is of GI origin (Burgess et al, 1971). Secondary involvement of the GI tract by NHL is also very common, although its incidence is much more difficult to ascertain.…”

mentioning

confidence: 99%

Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment

Sweetenham

Mead²,

Wright³

et al. 1989

Br J Cancer

View full text Add to dashboard Cite

“…Generally, the overall 5-year survival rate for gastric lymphoma is better than that for carcinoma [2,3]. Yet, when one compares lymphoma patients with carcinoma patients stage by stage, there is no definite difference in the survival rate of these groups [4,5].…”

mentioning

confidence: 99%